Hearing loss and tinnitus are common in cancer survivors

.

"Another important and previously unknown finding from our study is that these high rates of hearing loss and tinnitus occur not only with platinum drugs, but with another class of chemotherapy drugs called taxanes," he said."Given that platinum and taxane-containingare the ones most commonly used to treat the majority of cancers, these findings have huge implications for clinicians who treat cancer patients, as well as for cancer survivors.

The investigators found that more than 50 percent experienced significant hearing loss confirmed by an audiogram, a type of hearing exam, and more than 35 percent reported tinnitus. Additionally, the authors noted that because hearing loss is often underestimated, routine screening and follow-up should be done by hearing professionals. Individualized management plans for tinnitus require consultation with specialist clinicians.

Source: Healthcare Press (healthcarepress.net)

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

New Insight Into Nanoassemblies for Specific Cancer TherapyThe simple conjugation between boronic acid and RA allowed the formation of self-deliverable and self-immolating nanoassemblies that led to triple cooperative anticancer activity.
Source: AZoNano - 🏆 106. / 51 Read more »

Node.js prototype pollution is bad for app environmentBoffins find common code constructs that may be exploitable to achieve remote code execution
Source: TheRegister - 🏆 67. / 61 Read more »

Lena Dunham's bold new film on female sexuality, Sharp Stick: here's everything you need to knowUncomfortable, awkward but also sexy - Sharp Stick is about to be an interesting watch 👀
Source: GlamourMagUK - 🏆 2. / 98 Read more »

Sight loss charity hopes to build 72-bed care home in LeicestershireVista says the three-storey facility would be a 'centre of excellence for sight loss'.
Source: bbcemt - 🏆 120. / 51 Read more »